The role of YAP as a mediator of the effects exerted by RCS and AGEs was attested by the silencing experiments targeting this transcription regulator, which was previously shown to be critical in progression to PaC [24] and in MGO-induced breast tumour growth [23]. Here, YAP1 is linked to breast neoplasm.